Genetic Variants Associated With Breast-Cancer Risk: Comprehensive Research Synopsis, Meta-Analysis, and Epidemiological Evidence

The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(11)70076-6
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Elsevier BV

Related search

Correction: A Meta-Analysis of the Association Between ESR1 Genetic Variants and the Risk of Breast Cancer

PLoS ONE
Multidisciplinary
2018English

Frequency of 14 Genetic Variants Associated With Breast Cancer Risk and Treatment in a Colombian Population

Revista Colombiana de Ciencias Químico-Farmacéuticas
2018English

Genetic Variants of CYP19 (Aromatase) and Breast Cancer Risk

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

Systematic Review With Meta-Analysis of the Epidemiological Evidence Relating FEV1decline to Lung Cancer Risk

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

Genetic Variants in the MRPS30 Region and Postmenopausal Breast Cancer Risk

Genome Medicine
Molecular MedicineGeneticsMolecular Biology
2012English

NOD2 Polymorphisms Associated With Cancer Risk: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Mammographic Breast Density--Evidence for Genetic Correlations With Established Breast Cancer Risk Factors

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Angiotensin Converting Enzyme Insertion/Deletion Polymorphism Is Associated With Breast Cancer Risk: A Meta-Analysis

Asian Pacific Journal of Cancer Prevention
2018English

GSTM1 and GSTT1 Polymorphisms Are Associated With Increased Bladder Cancer Risk: Evidence From Updated Meta-Analysis

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy